MRK · 10-Q · 2026Q3 · Full report
Trade Policy and Tariffs
Merck & Co., Inc. · 2026-11-04 · Importance 40 · Surprise 42 · In source text
Merck reached an agreement with the U.S. Department of Commerce to delay Section 232 tariffs for three years. The delay enables the company to make U.S. investments to reshore manufacturing for American patients. The filing does not quantify the tariff exposure or planned investment amount.
Key facts
- Merck reached an agreement with the U.S. Department of Commerce to delay Section 232 tariffs for three years, enabling U.S. manufacturing reshoring investments. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | committed | — | Merck reached an agreement with the U.S. Department of Commerce to delay Section 232 tariffs for three years, enabling U.S. manufacturing… |